April 24, 2018 / 7:27 PM / a month ago

BRIEF-Otsuka's JYNARQUE Approved By FDA As First Treatment to Slow Kidney Function Decline

April 24 (Reuters) - Otsuka Pharmaceutical:

* U.S. FDA APPROVED JYNARQUE AS DRUG TREATMENT TO SLOW KIDNEY FUNCTION DECLINE IN ADULTS AT RISK OF RAPIDLY PROGRESSING ADPKD Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below